The size of the global contrast media market was worth USD 4.9 Billion in 2019 and estimated to grow at a CAGR of 4.65%, to reach USD 6.2 billion by 2024. The global Contrast Media market is developing at a rapid pace.
Contrast media used as a part of therapeutic imaging are grouped on the premise of imaging modalities. The two most customarily utilized contrast media are iodine-containing contrast medium and gadolinium contrast medium. The shade of structures in the body changes when pictures are caught with contrast media in the body. The delicate tissues are viewed as dim, while the bones look light-dark. The contrast media enhances the contrast between various parts of the body and classifies between multiple parts of the body that have comparative pieces.
MARKET DRIVERS
Increasing demand for MRI equipment and CT scanners due to the rise in preference among the public for accurate and faster diagnosis methods is a significant factor driving the global contrast media market. The growing adoption rate of technologically advanced systems such as CT express 3D contrast media delivery system and syringeless power injectors owing to the high demand and benefits associated with these systems such as minimal waste generation, automated collection of patient data and cost control are further accelerating the global contrast media market. Rising awareness levels of the public regarding the benefits associated with the early diagnosis is also favouring the market and estimated to contribute to the market growth.
MARKET RESTRAINTS
Factors such as side effects such as allergic reactions or adverse reactions on the body and like vomiting, nausea, constipation are likely to hamper the contrast media market growth to a small extent. Lack of reimbursement policies, economic slowdown, strict rules and regulatory approvals for the product launch and new inventions and lack of reimbursement policies are further expected to restrict the growth rate of the market slightly during the forecast period.
REPORT COVERAGE
|
REPORT METRIC |
DETAILS |
|
Market Size Available |
2018 to 2024 |
|
Base Year |
2018 |
|
Forecast Period |
2019 to 2024 |
|
Segments Covered |
By Medical Procedure, Route of Administration, Type, Indications, Application and Region |
|
Various Analyses Covered |
Global, Regional & Country Level Analysis, Segment-Level Analysis, Drivers, Restraints, Opportunities, Challenges, PESTLE Analysis, Porter’s Five Forces Analysis, Competitive Landscape, Analyst Overview on Investment Opportunities |
|
Regions Covered |
North America, Europe, Asia Pacific, Latin America, Middle East and Africa |
The report on the Global Contrast Media Market is segmented based on Procedure, Application, Route of Administration, Indication, Type, and Region.
Contrast Media Market – By Medical Procedure
Based on medical procedure, the ultrasound segment is likely to have the highest CAGR during the given forecast period. Development of microbubble contrast media for an ultrasound, a large number of approvals for ultrasound contrast media in the U.S., Europe, and Japan are some of the major factors driving the growth of this segment.
Contrast Media Market – By Route of Administration
Contrast Media Market – By Type
Based on type, the iodinated contrast media segment is contributing the largest share of revenues. It is likely to continue the trend over the forecast period due to the rise in account of CT scanning.
Contrast Media Market – By Indications
Based on indications, the cardiovascular disorders segment is likely to hold the lion's share and witness the highest growth rate during the outlook period. Growing enhancements in cardiac MRI procedures, favourable government reimbursement policies for contrast media in cardiovascular diagnosis, and robust infrastructure in the healthcare of developed countries are some of the factors driving this segment.
Contrast Media Market – By Application
Based on application, the interventional cardiology segment is dominating the global contrast media market among the applications. It is likely to grow at high CAGR owing to the rise in the prevalence of cardiovascular diseases and the increasing adoption rate of minimally invasive surgical techniques.
The Radiology segment is another significant market division and is contributing a substantial share of revenues to the contrast media market.
Contrast Media Market – By Region
Geographically, the North American region is estimated to constitute the largest share of this market. In contrast, the Asia Pacific region is expected to witness the fastest growth and overtake North America, being the second-largest shareholder for the market during the forecast period. Existence of well-established healthcare facilities, accessibility of technological advancements, and big stipulation for diagnostic procedures are some of the factors accelerating the North American contrast media market. The United States market is estimated to hold the majority of the market share in this region, followed by Canada.
Europe is the 2nd largest market in the global market. A large number of MRI scans performed in European countries such as France and Germany are expected to continue driving market growth in this region.
However, the Asia-Pacific region is projected to grow at the highest CAGR due to increasing elder people population suffering from spinal problems, fractures and health issues alongside the growing patient pool, which is expanding stipulation for medical imaging and growing rate of cardiac disorders are propelling the Asia Pacific market growth. Japan was the market leader in the Asia Pacific market in 2019.
Latin America is expected to have steady growth during the forecast period. Factors such as growing occurrence rate of cardiac and cancer disorders and technology advancements towards the diagnostic technology are actively supporting the market in this region.
The Middle East & Africa region is estimated to have sluggish growth rate due to the factors such as growing diagnostic centres, hospitals and clinics.
TOP COMPANIES IN THE MARKET
Notable companies leading the global contrast media market profiled in this report are CMC Contrast AB (Sweden), Daiichi Sankyo (Japan), Bayer HealthCare (Germany), GE Healthcare (U.S.), Guerbet Group (France), Bracco Imaging S.p.A. (Italy), Lantheus Medical Imaging (U.S.), nanoPET Pharma GmbH (Germany) and Subhra Pharma Private Limited (India)
KEY HAPPENINGS IN THIS MARKET IN THE RECENT PAST:
In 2019, Researchers of Massachusetts general hospital had developed a novel, safer and effective contrast media based on manganese (Mn-PyC3A). Based on the studies conducted by the researchers, the novel manganese-based contrast media provides enhanced tumour contrast without interacting with the cells and tissues. The researchers concluded that the new contrast media offers better efficiency than the gadolinium-based contrast media, which can potentially make MRIs a lot safer practice.
In 2017, GE healthcare's product called visipaque had received approval to expand the indication by the FDA. With this approval, the injection can be adopted in CCTA for diagnostics of patients with coronary artery disease. With the expansion of the visipaque label, the physicians can practice non-invasive imaging of coronary arteries. It is the first iodinated contrast media that is approved by the FDA as an application in CCTA, and the recovery of patients is much faster due to its non-invasive nature.
1.Introduction
1.1 Market Definition
1.2 Study Deliverables
1.3 Base Currency, Base Year and Forecast Periods
1.4 General Study Assumptions
2. Research Methodology
2.1 Introduction
2.2 Research Phases
2.2.1 Secondary Research
2.2.2 Primary Research
2.2.3 Econometric Modelling
2.2.4 Expert Validation
2.3 Analysis Design
2.4 Study Timeline
3. Overview
3.1 Executive Summary
3.2 Key Inferences
3.3 Epidemology
4. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)
4.1 Market Drivers
4.2 Market Restraints
4.3 Key Challenges
4.4 Current Opportunities in the Market
5. Market Segmentation
5.1 Medical Procedure
5.1.1 Introduction
5.1.2 X-Ray/CT
5.1.3 MRI
5.1.4 Ultrasound
5.1.5 Y-o-Y Growth Analysis, By Medical Procedure
5.1.6 Market Attractiveness Analysis, By Medical Procedure
5.1.7 Market Share Analysis, By Medical Procedure
5.2 Route of Administration
5.2.1 Introduction
5.2.2 Injectable Contrasts Media
5.2.3 Oral Contrasts Media
5.2.4 Rectal Contrasts Media
5.2.5 Urethral Contrasts Media
5.2.6 Y-o-Y Growth Analysis, By Route of Administration
5.2.7 Market Attractiveness Analysis, By Route of Administration
5.2.8 Market Share Analysis, By Route of Administration
5.3 Type
5.3.1 Introduction
5.3.2 Iodinated Contrasts Media
5.3.3 Gadolinium-Based Contrasts Media
5.3.4 Microbubble Contrasts Media
5.3.5 Barium- Based Contrasts Media
5.3.6 Y-o-Y Growth Analysis, By Type
5.3.7 Market Attractiveness Analysis, By Type
5.3.8 Market Share Analysis, By Type
5.4 Indications
5.4.1 Introduction
5.4.2 Cardiovascular Disorders
5.4.3 Oncology
5.4.4 Neurological Disorders
5.4.5 Gastrointestinal Disorders
5.4.6 Nephrological Disorders
5.4.7 Musculoskeletal Disorders
5.4.8 Y-o-Y Growth Analysis, By Indications
5.4.9 Market Attractiveness Analysis, By Indications
5.4.10 Market Share Analysis, By Indications
5.5 Application
5.5.1 Introduction
5.5.2 Radiology
5.5.3 Interventional Cardiology
5.5.4 Interventional Radiology
5.5.5 Y-o-Y Growth Analysis, By Application
5.5.6 Market Attractiveness Analysis, By Application
5.5.7 Market Share Analysis, By Application
6. Geographical Analysis
6.1 Introduction
6.1.1 Regional Trends
6.1.2 Impact Analysis
6.1.3 Y-o-Y Growth Analysis
6.1.3.1 By Geographical Area
6.1.3.2 By Medical Procedure
6.1.3.3 By Route of Administration
6.1.3.4 By Type
6.1.3.5 By Indication
6.1.3.6 By Application
6.1.4 Market Attractiveness Analysis
6.1.4.1 By Geographical Area
6.1.4.2 By Medical Procedure
6.1.4.3 By Route of Administration
6.1.4.4 By Type
6.1.4.5 By Indication
6.1.4.6 By Application
6.1.5 Market Share Analysis
6.1.5.1 By Geographical Area
6.1.5.2 By Medical Procedure
6.1.5.3 By Route of Administration
6.1.5.4 By Type
6.1.5.5 By Indication
6.1.5.6 By Application
6.2 North America
6.1.1 Introduction
6.1.2 United States
6.1.3 Canada
6.3 Europe
6.2.1 Introduction
6.2.2 U.K
6.2.3 Spain
6.2.4 Germany
6.2.5 Italy
6.2.6 France
6.4 Asia-Pacific
6.3.1 Introduction
6.3.2 China
6.3.3 India
6.3.4 Japan
6.3.5 Australia
6.3.6 South Korea
6.5 Latin America
6.4.1 Introduction
6.4.2 Brazil
6.4.3 Argentina
6.4.4 Mexico
6.4.5 Rest of Latin America
6.6 Middle East & Africa
6.5.1 Introduction
6.5.2 Middle-East
6.5.3 Africa
7.Strategic Analysis
7.1 PESTLE analysis
7.1.1 Political
7.1.2 Economic
7.1.3 Social
7.1.4 Technological
7.1.5 Legal
7.1.6 Environmental
7.2 Porter’s Five analysis
7.2.1 Bargaining Power of Suppliers
7.2.2 Bargaining Power of Consumers
7.2.3 Threat of New Entrants
7.2.4 Threat of Substitute Products and Services
7.2.5 Competitive Rivalry within the Industry
8.Market Leaders' Analysis
8.1 GE Healthcare
8.1.1 Overview
8.1.2 Medical Procedure Analysis
8.1.3 Financial analysis
8.1.4 Recent Developments
8.1.5 SWOT analysis
8.1.6 Analyst View
8.2 Spago Nanomedical AB
8.3 Subhra Pharma Private Limited
8.4 Daiichi Sankyo
8.5 CMC Contrast AB
8.6 Nanopet Pharma GmbH
8.7 Guerbet Group
8.8 Bracco Imaging S.P.A
8.9 Bayer AG
8.10 Lantheus Medical Imaging (Subsidiary of Lantheus Holdings, Inc.)
9.Competitive Landscape
9.1 Market share analysis
9.2 Merger and Acquisition Analysis
9.3 Agreements, collaborations and Joint Ventures
9.4 New Product Launches
10.Market Outlook and Investment Opportunities
Appendix
a) List of Tables
b) List of Figures
Related Reports
Feb 2020
Download Sample
Feb 2020
Download Sample
Feb 2020
Download Sample
Feb 2020
Download Sample
